← Back to Search

Condition 11 for Obesity (BUILD Trial)

N/A
Recruiting
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Married/cohabitating couple - both partners must be eligible
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights

BUILD Trial Summary

This trial aims to improve the effectiveness of an online couples weight loss program. They will test different strategies, such as action planning and partner support, alongside the core program using a unique method called Multiph

Who is the study for?
This trial is for married or cohabitating couples where both partners are overweight (BMI between 25-55), speak and read English, have a smartphone with internet access, an active email address, and are willing to videoconference. Both must meet the criteria to participate.Check my eligibility
What is being tested?
The study tests four strategies to boost weight loss in couples using an online program: dyadic action planning, joint feedback on goals, training to support each other's autonomy, and changes in the home environment. These will be added to a core behavioral weight loss intervention.See study design
What are the potential side effects?
Since this trial involves lifestyle interventions rather than medication, typical medical side effects aren't expected. Participants may experience stress or tension from lifestyle changes or relationship dynamics during the study.

BUILD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My partner and I are both eligible and live together.

BUILD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight (kg)
Secondary outcome measures
Dietary Intake
Goal Coordination (Wingrove Goal Coordination Scale)
Home Exercise Environment (Exercise Environment Questionnaire)
+4 more

BUILD Trial Design

16Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment2 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning
Group II: Condition 8Experimental Treatment4 Interventions
1) Core BWL Intervention; 2) Joint Feedback; 3) Autonomy Support Training; 4) Home Environment Modifications
Group III: Condition 7Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Joint Feedback; 3) Autonomy Support Training
Group IV: Condition 6Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Joint Feedback; 3) Home Environment Modifications
Group V: Condition 5Experimental Treatment2 Interventions
1) Core BWL Intervention; 2) Joint Feedback
Group VI: Condition 4Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Autonomy Support Training; 3) Home Environment Modifications
Group VII: Condition 3Experimental Treatment2 Interventions
1) Core BWL Intervention; 2) Autonomy Support Training
Group VIII: Condition 2Experimental Treatment2 Interventions
1) Core BWL Intervention; 2) Home Environment Modifications
Group IX: Condition 16Experimental Treatment5 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Joint Feedback; 4) Autonomy Support Training; 5) Home Environment Modifications
Group X: Condition 15Experimental Treatment4 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Joint Feedback; 4) Autonomy Support Training
Group XI: Condition 14Experimental Treatment4 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Joint Feedback; 4) Home Environment Modifications
Group XII: Condition 13Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Joint Feedback
Group XIII: Condition 12Experimental Treatment4 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Autonomy Support Training 4) Home Environment Modifications
Group XIV: Condition 11Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Autonomy Support Training
Group XV: Condition 10Experimental Treatment3 Interventions
1) Core BWL Intervention; 2) Dyadic Action Planning; 3) Home Environment Modifications
Group XVI: Condition 1Experimental Treatment1 Intervention
1) Core BWL Intervention

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor
184 Previous Clinical Trials
157,557 Total Patients Enrolled
22 Trials studying Obesity
4,809 Patients Enrolled for Obesity
University of North Carolina, Chapel HillOTHER
1,508 Previous Clinical Trials
4,190,089 Total Patients Enrolled
65 Trials studying Obesity
58,054 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,313,856 Total Patients Enrolled
447 Trials studying Obesity
588,938 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction on the eligibility criteria for participants, specifically regarding individuals above 70 years old?

"The study is seeking participants aged over 18 years but under 75 years."

Answered by AI

How many participants are currently undergoing treatment in this medical study?

"Affirmative. The details on clinicaltrials.gov highlight that this ongoing medical investigation is currently seeking eligible participants. Initially shared on February 1st, 2024, the trial's latest update was made on February 8th, 2024. A total of 736 patients are sought from a single designated site."

Answered by AI

Is this clinical trial currently accepting new participants?

"Indeed, the information on clinicaltrials.gov shows that this ongoing study is actively seeking participants. The trial was first listed on February 1st, 2024 and most recently revised on February 8th, 2024. Currently, there is a need to enroll 736 patients at a single location."

Answered by AI
~491 spots leftby Feb 2027